Nutr Rev 80:12371246
Another class of medications initially developed for the treatment of high blood glucose in patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitors (SGLT2i), has also been demonstrated to reduce cardiovascular risk, with corresponding FDA product label changes and professional society recommendations endorsing their use
A study by Batsis and Villareal (2018) published in the Journal of Clinical Investigation found that combining calorie restriction with resistance training preserved significantly more lean mass than calorie restriction alone
Blood Sugar Changes For people with type 2 diabetes or insulin resistance, blood sugar levels may rise as the glucose-lowering effects of semaglutide fade
If you want personalized insight into how your genetics influence GLP-1 receptor activity and peptide pathways, PlexusDx offers the Precision Peptide Genetic Test for $99 as an add-on after your first month of treatment
Gradual weight loss helps reduce the risk of: Muscle loss Fatigue Nutrient deficiencies Regaining weight later Tirzepatide is designed to support steady, sustainable change rather than rapid drops on the scale
